Advertisement

Management of Conjunctival Neoplasms

  • Stella K. KimEmail author
  • Dan S. Gombos
  • Bita Esmaeli
Chapter
Part of the M.D. Anderson Solid Tumor Oncology Series book series (MDA, volume 6)

Abstract

Melanocytic neoplasms of the conjunctiva include nevus, primary acquired melanosis (PAM) without atypia, PAM with atypia, and conjunctival melanoma. The most common nonmelanocytic tumors of the conjunctiva are squamous cell neoplasms. Surgical excision is the cornerstone of therapy for conjunctival tumors. Proper specimen handling is critical to ensure that lesion orientation is clear to the ocular pathologist. Adjuvant therapy for conjunctival tumors can include cryotherapy and/or topical chemotherapy with mitomycin C, 5-fluorouracil, or interferon, or adjuvant radiation therapy. Tumor thickness and ulceration are important prognostic factors for local control and survival for conjunctival melanomas. Sentinel lymph node biopsy is an important recent consideration for conjunctival melanomas that are thicker than 2 mm or those that have histologic evidence of ulceration.

Keywords

Sentinel Lymph Node Biopsy Invasive Squamous Cell Carcinoma Melanocytic Lesion Invasive Melanoma Melanocytic Neoplasm 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Scott IU, Karp CL, Nuovo GJ. Human papillomavirus 16 and 18 expression in conjunctival intraepithelial neoplasia. Ophthalmology 2002;109(3):542–7.PubMedCrossRefGoogle Scholar
  2. 2.
    Shelil AE, Shields CL, Shields JA, et al. Aggressive conjunctival squamous cell carcinoma in a patient following liver transplantation. Arch Ophthalmol 2003;121(2):280–2.PubMedCrossRefGoogle Scholar
  3. 3.
    Shields JA, Shields CL, Gunduz K, et al. The 1998 Pan American lecture. Intraocular invasion of conjunctival squamous cell carcinoma in five patients. Ophthal Plast Reconstr Surg 1999;15(3):153–60.PubMedCrossRefGoogle Scholar
  4. 4.
    Brownstein S. Mucoepidermoid carcinoma of the conjunctiva with intraocular invasion. Ophthalmology 1981;88(12):1226–30.PubMedGoogle Scholar
  5. 5.
    Shields JA, Shields CL, De Potter P. Surgical management of conjunctival tumors. The 1994 Lynn B. McMahan lecture. Arch Ophthalmol 1997;115(6):808–15.PubMedCrossRefGoogle Scholar
  6. 6.
    Eichler MD, Fraunfelder FT. Cryotherapy for conjunctival lymphoid tumors. Am J Ophthalmol 1994;118(4):463–7.PubMedGoogle Scholar
  7. 7.
    Karp CL, Moore JK, Rosa RH Jr. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Ophthalmology 2001;108(6):1093–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Midena E, Angeli CD, Valenti M, et al. Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil. Br J Ophthalmol 2000;84(3):268–72.PubMedCrossRefGoogle Scholar
  9. 9.
    Shields CL, Naseripour M, Shields JA, et al. Topical mitomycin-C for pagetoid invasion of the conjunctiva by eyelid sebaceous gland carcinoma. Ophthalmology 2002;109(11):2129–33.PubMedCrossRefGoogle Scholar
  10. 10.
    Yeatts RP, Engelbrecht NE, Curry CD, et al. 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. Ophthalmology 2000;107(12):2190–5.PubMedCrossRefGoogle Scholar
  11. 11.
    Shields JA, Shields CL, Suvarnamani C, et al. Orbital exenteration with eyelid sparing: indications, technique, and results. Ophthalmic Surg 1991;22(5):292–7.PubMedGoogle Scholar
  12. 12.
    Shields JA, Shields CL, Demirci H, et al. Experience with eyelid-sparing orbital exenteration: the 2000 Tullos O. Coston lecture. Ophthal Plast Reconstr Surg 2001;17(5):355–61.PubMedCrossRefGoogle Scholar
  13. 13.
    Esmaeli B, Eicher S, Popp J, et al. Sentinel lymph node biopsy for conjunctival melanoma. Ophthal Plast Reconstr Surg 2001;17(6):436–42.PubMedCrossRefGoogle Scholar
  14. 14.
    Folberg R, Jakobiec FA, Bernardino VB, et al. Benign conjunctival melanocytic lesions. Clinicopathologic features. Ophthalmology 1989;96(4):436–61.PubMedGoogle Scholar
  15. 15.
    Jakobiec FA, Folberg R, Iwamoto T. Clinicopathologic characteristics of premalignant and malignant melanocytic lesions of the conjunctiva. Ophthalmology 1989;96(2):147–66.PubMedGoogle Scholar
  16. 16.
    Jay B. Naevi and melanomata of the conjunctiva. Br J Ophthalmol 1965;49:169–204.PubMedCrossRefGoogle Scholar
  17. 17.
    Liesegang TJ, Campbell RJ. Mayo Clinic experience with conjunctival melanomas. Arch Ophthalmol 1980;98(8):1385–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Shields CL, Fasiuddin AF, Mashayekhi A, et al. Conjunctival nevi: clinical features and natural course in 410 consecutive patients. Arch Ophthalmol 2004;122(2):167–75.PubMedCrossRefGoogle Scholar
  19. 19.
    McDonnell JM, Carpenter JD, Jacobs P, et al. Conjunctival melanocytic lesions in children. Ophthalmology 1989;96(7):986–93.PubMedGoogle Scholar
  20. 20.
    Brancato R, Campana G, Mincione G. Histopathogenetic considerations on the so-called cystic nevi of the conjunctiva [in Italian]. Arch De Vecchi Anat Patol 1969;54(3):739–46.PubMedGoogle Scholar
  21. 21.
    Folberg R, McLean IW, Zimmerman LE. Conjunctival melanosis and melanoma. Ophthalmology 1984;91(6):673–8.PubMedGoogle Scholar
  22. 22.
    Jakobiec FA. The ultrastructure of conjunctival melanocytic tumors. Trans Am Ophthalmol Soc 1984;82:599–752.PubMedGoogle Scholar
  23. 23.
    Folberg R, McLean IW. Primary acquired melanosis and melanoma of the conjunctiva: terminology, classification, and biologic behavior. Hum Pathol 1986;17(7):652–4.PubMedCrossRefGoogle Scholar
  24. 24.
    Shields JA, Shields CL, Mashayekhi A, et al. Primary acquired melanosis of the conjunctiva: experience with 311 eyes. Trans Am Ophthalmol Soc 2007;105:61–71.PubMedGoogle Scholar
  25. 25.
    Jakobiec FA, Rini FJ, Fraunfelder FT, et al. Cryotherapy for conjunctival primary acquired melanosis and malignant melanoma. Experience with 62 cases. Ophthalmology 1988;95(8):1058–70.PubMedGoogle Scholar
  26. 26.
    Jakobiec FA, Brownstein S, Wilkinson RD, et al. Adjuvant cryotherapy for focal nodular melanoma of the conjunctiva. Arch Ophthalmol 1982;100(1):115–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Gloor P, Alexandrakis G. Clinical characterization of primary acquired melanosis. Invest Ophthalmol Vis Sci 1995;36(8):1721–9.PubMedGoogle Scholar
  28. 28.
    Paridaens D, Beekhuis H, van Den Bosch W, et al. Amniotic membrane transplantation in the management of conjunctival malignant melanoma and primary acquired melanosis with atypia. Br J Ophthalmol 2001;85(6):658–61.PubMedCrossRefGoogle Scholar
  29. 29.
    Finger PT, Czechonska G, Liarikos S. Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia. Br J Ophthalmol 1998;82(5):476–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Kurli M, Finger PT. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years’ experience. Graefes Arch Clin Exp Ophthalmol 2005;243(11):1108–14.PubMedCrossRefGoogle Scholar
  31. 31.
    Finger PT, Sedeek RW, Chin KJ. Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex. Am J Ophthalmol 2008;145(1):124–9.PubMedCrossRefGoogle Scholar
  32. 32.
    Chalasani R, Giblin M, Conway RM. Role of topical chemotherapy for primary acquired melanosis and malignant melanoma of the conjunctiva and cornea: review of the evidence and recommendations for treatment. Clin Exp Ophthalmol 2006;34(7):708–14.CrossRefGoogle Scholar
  33. 33.
    Scotto J, Fraumeni JF Jr., Lee JA. Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. J Natl Cancer Inst 1976;56(3):489–91.PubMedGoogle Scholar
  34. 34.
    Paridaens AD, Minassian DC, McCartney AC, et al. Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases. Br J Ophthalmol 1994;78(4):252–9.PubMedCrossRefGoogle Scholar
  35. 35.
    Shields CL, Shields JA, Gunduz K, et al. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Arch Ophthalmol 2000;118(11):1497–507.PubMedCrossRefGoogle Scholar
  36. 36.
    Jakobiec FA. Conjunctival melanoma. Arch Ophthalmol 1980;98(8):1378–84.PubMedCrossRefGoogle Scholar
  37. 37.
    Savar A, Ross MI, Prieto VG, et al. Sentinel lymph node biopsy for ocular adnexal melanoma: experience in 30 patients. Ophthalmology 2009;116(11):2217–23.PubMedCrossRefGoogle Scholar
  38. 38.
    Esmaeli B, Wang X, Youssef A, et al. Patterns of regional and distant metastasis in patients with conjunctival melanoma: experience at a cancer center over four decades. Ophthalmology 2001;108(11):2101–5.PubMedCrossRefGoogle Scholar
  39. 39.
    Jakobiec FA, Brownstein S, Wilkinson RD, et al. Combined surgery and cryotherapy for diffuse malignant melanoma of the conjunctiva. Arch Ophthalmol 1980;98(8):1390–6.PubMedCrossRefGoogle Scholar
  40. 40.
    Esmaeli B, De Martelaere S, Ozkan Y, et al. Surgical specimen handling for conjunctival melanoma: implications for tumor thickness determination and sentinel lymph node biopsy. Ophthal Plast Reconstr Surg 2006;22(3):238–9.PubMedCrossRefGoogle Scholar
  41. 41.
    Hsu A, Frank S, Ballo MT, et al. Postoperative adjuvant external-beam radiation therapy for cancers of the eyelid and conjunctiva. Ophthal Plast Reconstr Surg 2008;24(6):444–9.PubMedCrossRefGoogle Scholar
  42. 42.
    Esmaeli B. Sentinel lymph node mapping for patients with cutaneous and conjunctival malignant melanoma. Ophthal Plast Reconstr Surg 2000;16(3):170–2.PubMedCrossRefGoogle Scholar
  43. 43.
    Esmaeli B. Sentinel node biopsy as a tool for accurate staging of eyelid and conjunctival malignancies. Curr Opin Ophthalmol 2002;13(5):317–23.PubMedCrossRefGoogle Scholar
  44. 44.
    Wilson MW, Fleming JC, Fleming RM, et al. Sentinel node biopsy for orbital and ocular adnexal tumors. Ophthal Plast Reconstr Surg 2001;17(5):338–44; discussion 44–5.PubMedCrossRefGoogle Scholar
  45. 45.
    Esmaeli B, Reifler D, Prieto VG, et al. Conjunctival melanoma with a positive sentinel lymph node. Arch Ophthalmol 2003;121(12):1779–83.PubMedCrossRefGoogle Scholar
  46. 46.
    Nijhawan N, Ross MI, Diba R, et al. Experience with sentinel lymph node biopsy for eyelid and conjunctival malignancies at a cancer center. Ophthal Plast Reconstr Surg 2004;20(4):291–5.PubMedCrossRefGoogle Scholar
  47. 47.
    Ho VH, Ross MI, Prieto VG, et al. Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa. Arch Otolaryngol Head Neck Surg 2007;133(8):820–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Section of Ophthalmology, Department of Head and Neck SurgeryThe University of Texas M.D. Anderson Cancer CenterHoustonUSA

Personalised recommendations